Abstract
Urethane is a chemical carcinogen which causes lung tumorigenesis in mice with similarities to human adenocarcinoma (AC). The sphingosine 1-phosphate agonist FTY720 administered to mice in doses above 5 mg/kg/day has been able to prevent hepatocellular carcinoma and bladder cancer. We used BALB/c mice in urethane-induced lung cancer model to investigate the effects of a lower dose of FTY720 (1 mg/kg/day). The benefits of FTY720 were associated with the time point of the compound administration. FTY720 30 Group presented lower incidence and smaller area of lung nodules, decreased PCNA and increased Caspase-3 expressions. The findings in FTY720 0 Group (nodule multiplicity and area, PCNA expression) were similar to Urethane Group suggesting that the administration of the compound at early time point did not affect lung tumor development. FTY720 90 Group presented the biggest nodule area which was associated with increased PCNA and decreased Caspase-3 expressions. FTY720 (30 days and 90 days) administration decreased CD4 + splenocytes and blood lymphocytes which caused opposite effects in lung tumor development - impairment and improvement respectively.
In conclusion, FTY720 in low dose did not provide lung tumor inhibition in mice but its administration 30 days after the chemical carcinogen (Urethane) injection was associated with impaired tumor development
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Malkinson AM, Beer DS (1983) Major effect on susceptibility to urethane-induced pulmonary adenoma by a single gene in BALB/cBy mice. J Natl Cancer Inst 70:931–936
Malkinson AM (1998) Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp Lung Res 24:541–555
Manson RJ, Kalina M, Nielsen LDet al (2000) Surfactant protein C expression in urethane-induced murine pulmonary tumors. Am J Pathol 156:175–182
Wang M, Devereux TR, Vikis HGet al (2004) Pol ioto is a candidate for the mouse pulmonary adenoma resistance 2 locus, a major modifier of chemically induced lung neoplasia. Cancer Res 64:1924–1931
O'Donnell EP, Zerbe LK, Dwyer-Nield LDet al (2006) Quantitative analysis of early chemically-induced pulmonary lesions in mice of varying susceptibilities to lung tumorigenesis. Cancer Lett 241:197–202
Karasaki H, Obata M, Ogawa K, Lee GH (1997) Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations. Oncogene 15:1833–1840
Stathopoulos GT, Sherrill TP, Cheng D-Set al (2007) Epithelial NF-κB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci U S A 104:18514–18519
LaMontagne K, Littlewood-Evans A, Schnell Cet al (2006) Antagonism of sphigosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res 66:221–231
Azuma H, Takahara S, Ichimaru Net al (2002) Marked Prevention of Tumor Growth and Metastasis by a Novel Immunosuppressive Agent, FTY720, in Mouse Breast Cancer Models. Cancer Res 62:1410–1419
Azuma H, Takahara S, Horie Set al (2003) Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. J Urol 169:2372–2377
Schmid G, Guba M, Papyan Aet al (2005) FTY720 inhibits tumor growth and angiogenesis. Transplant Proc 37:110–111
Chua CW, Lee DT, Ling MTet al (2005) FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer. Int J Cancer 117:1039–1048
Lee TK, Man K, Ho JWet al (2005) FTY720: a promising agent for treatment of metastaic hepatocellular carcinoma. Clin Cancer Res 11:8458–8466
Silva LBL, Ribeiro DA, Cury PMet al (2008) FTY720 treatment in experimentally urethane-induced lung tumors. J Exp Ther Oncol 7:9–15
Monobe Y, Manabe T (1995) Morphological changes and proliferative activity of alveolar epithelium in mouse lungs treated with urethane. Virchows Arch 425:583–588
Cha SW, Lee HJ, Cho MHet al (2001) Role of corticosterone in ethyl carbamate-induced immunosuppression in female BALB/c mice. Toxicol Lett 119:173–181
Yokota K, Hattori A, Kunz HWet al (1989) Experimental analysis of the effects of cyclosporine on the induction of epithelial tumors. Transplant Proc 21:3211–3214
Caracia RL, Coltera MD, Gown AM (1989) Analysis of proliferative embedded tissues: comparison with flow cytometric analysis. Am J Pathol 134:733–739
Hall PA, Levison DA, Woods AL, Yu CWet al (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasm. J Pathol 162:285–294
Hung JJ, Wang CY, Huang MHet al (2007) Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg 134:638–643
Radović S, Babić M, Dorić Met al (2007) Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors. Bosn J Basic Med Sci 7:205–211
Wang JD, Takahara S, Nonomura Net al (1999) Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation. Prostate 40:50–55
Malkinson AM (2005) Role of inflammation in mouse lung tumorigenesis: a review. Exp Lung Res 31:57–82
Matsuoka Y, Nagahara Y, Ikekita M, Shinomiya T (2003) A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. Br J Pharmacol 138:1303–1312
Acknowledgments
This project was supported by FAPESP and CNPq
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salinas, N.R., Lopes, C.T., Palma, P.V. et al. Lung Tumor Development in the Presence of Sphingosine 1-phosphate Agonist FTY720. Pathol. Oncol. Res. 15, 549–554 (2009). https://doi.org/10.1007/s12253-009-9152-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-009-9152-2